DOR/ISL (doravirine/islatravir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DOR/ISL (doravirine/islatravir), covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054) [Phase 3]